Status:
COMPLETED
CAPRIVI: Community Acquired Pneumonia: Treatment With Avelox® in Hospitalized Patients
Lead Sponsor:
Bayer
Conditions:
Pneumonia
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to obtain data from hospitalized Community Acquired Pneumonia (CAP) patients on the disease including disease severity, clinical signs and symptoms and measures used for diagn...
Eligibility Criteria
Inclusion
- Adult hospitalized patients with a diagnosis of CAP (based on local medical practice) and decision taken by the investigator to treat with moxifloxacin and to start treatment with intravenous administration. The local moxifloxacin product information must be considered.
Exclusion
- Contraindications stated in the local moxifloxacin product information; warnings and precautions must be considered.
Key Trial Info
Start Date :
September 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
2595 Patients enrolled
Trial Details
Trial ID
NCT00987792
Start Date
September 1 2009
End Date
October 1 2012
Last Update
August 7 2015
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Croatia
2
Many Locations, France
3
Many Locations, Hungary
4
Many Locations, Jordan